These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
610 related articles for article (PubMed ID: 2173752)
1. Opioid agonist and antagonist antinociceptive properties of [D-Ala2,Leu5,Cys6]enkephalin: selective actions at the deltanoncomplexed site. Qi JA; Bowen WD; Mosberg HI; Rothman RB; Porreca F J Pharmacol Exp Ther; 1990 Nov; 255(2):636-41. PubMed ID: 2173752 [TBL] [Abstract][Full Text] [Related]
2. Differential antagonism of opioid delta antinociception by [D-Ala2,Leu5,Cys6]enkephalin and naltrindole 5'-isothiocyanate: evidence for delta receptor subtypes. Jiang Q; Takemori AE; Sultana M; Portoghese PS; Bowen WD; Mosberg HI; Porreca F J Pharmacol Exp Ther; 1991 Jun; 257(3):1069-75. PubMed ID: 1646319 [TBL] [Abstract][Full Text] [Related]
3. Spinal opioid delta antinociception in the mouse: mediation by a 5'-NTII-sensitive delta receptor subtype. Mattia A; Farmer SC; Takemori AE; Sultana M; Portoghese PS; Mosberg HI; Bowen WD; Porreca F J Pharmacol Exp Ther; 1992 Feb; 260(2):518-25. PubMed ID: 1310737 [TBL] [Abstract][Full Text] [Related]
4. Modulation of mu-mediated antinociception in the mouse involves opioid delta-2 receptors. Porreca F; Takemori AE; Sultana M; Portoghese PS; Bowen WD; Mosberg HI J Pharmacol Exp Ther; 1992 Oct; 263(1):147-52. PubMed ID: 1328602 [TBL] [Abstract][Full Text] [Related]
5. Antinociceptive properties of two alkylating derivatives of morphinone: 14 beta-(thioglycolamido)-7,8-dihydromorphinone (TAMO) and 14 beta-(bromoacetamido)-7,8-dihydromorphinone (H2BAMO). Jiang Q; Seyed-Mozaffari A; Archer S; Bidlack JM J Pharmacol Exp Ther; 1992 Aug; 262(2):526-31. PubMed ID: 1380079 [TBL] [Abstract][Full Text] [Related]
6. Opioid modulation of basal intestinal fluid transport in the mouse: actions at central, but not intestinal, sites. Jiang Q; Sheldon RJ; Porreca F J Pharmacol Exp Ther; 1990 May; 253(2):784-90. PubMed ID: 2160010 [TBL] [Abstract][Full Text] [Related]
7. Enhancement of morphine antinociception by a CCKB antagonist in mice is mediated via opioid delta receptors. Vanderah TW; Bernstein RN; Yamamura HI; Hruby VJ; Porreca F J Pharmacol Exp Ther; 1996 Jul; 278(1):212-9. PubMed ID: 8764354 [TBL] [Abstract][Full Text] [Related]
8. Role of mu and delta receptors in the supraspinal and spinal analgesic effects of [D-Pen2, D-Pen5]enkephalin in the mouse. Porreca F; Heyman JS; Mosberg HI; Omnaas JR; Vaught JL J Pharmacol Exp Ther; 1987 May; 241(2):393-400. PubMed ID: 3033214 [TBL] [Abstract][Full Text] [Related]
9. Differential modulation by [D-Pen2, D-Pen5]enkephalin and dynorphin A-(1-17) of the inhibitory bladder motility effects of selected mu agonists in vivo. Sheldon RJ; Nunan L; Porreca F J Pharmacol Exp Ther; 1989 May; 249(2):462-9. PubMed ID: 2566676 [TBL] [Abstract][Full Text] [Related]
10. Evidence for delta receptor mediation of [D-Pen2,D-Pen5]-enkephalin (DPDPE) analgesia in mice. Heyman JS; Mosberg HI; Porreca F NIDA Res Monogr; 1986; 75():442-5. PubMed ID: 2828989 [TBL] [Abstract][Full Text] [Related]
11. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord. He L; Lee NM J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421 [TBL] [Abstract][Full Text] [Related]
12. Characterization of D-Ala2,Leu5,Cys6-enkephalin: a novel synthetic opioid peptide with slowed dissociation from delta receptors. Bowen WD; Kelemen M; Huey R; Stewart D NIDA Res Monogr; 1986; 75():193-6. PubMed ID: 2828971 [TBL] [Abstract][Full Text] [Related]
14. Modulation of the potency and efficacy of mu-mediated antinociception by delta agonists in the mouse. Qi JN; Mosberg HI; Porreca F J Pharmacol Exp Ther; 1990 Aug; 254(2):683-9. PubMed ID: 2166801 [TBL] [Abstract][Full Text] [Related]
15. Heroin acts on different opioid receptors than morphine in Swiss Webster and ICR mice to produce antinociception. Rady JJ; Roerig SC; Fujimoto JM J Pharmacol Exp Ther; 1991 Feb; 256(2):448-57. PubMed ID: 1847196 [TBL] [Abstract][Full Text] [Related]
16. Modulation of morphine antinociception by swim-stress in the mouse: involvement of supraspinal opioid delta-2 receptors. Vanderah TW; Wild KD; Takemori AE; Sultana M; Portoghese PS; Bowen WD; Hruby VJ; Mosberg HI; Porreca F J Pharmacol Exp Ther; 1993 Oct; 267(1):449-55. PubMed ID: 8229774 [TBL] [Abstract][Full Text] [Related]
17. Dissociation of opioid antinociception and central gastrointestinal propulsion in the mouse: studies with naloxonazine. Heyman JS; Williams CL; Burks TF; Mosberg HI; Porreca F J Pharmacol Exp Ther; 1988 Apr; 245(1):238-43. PubMed ID: 2834537 [TBL] [Abstract][Full Text] [Related]
18. Differential regulation of mu and delta opiate receptors by morphine, selective agonists and antagonists and differentiating agents in SH-SY5Y human neuroblastoma cells. Zadina JE; Harrison LM; Ge LJ; Kastin AJ; Chang SL J Pharmacol Exp Ther; 1994 Sep; 270(3):1086-96. PubMed ID: 7932156 [TBL] [Abstract][Full Text] [Related]
19. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice. Ward SJ; Takemori AE J Pharmacol Exp Ther; 1983 Mar; 224(3):525-30. PubMed ID: 6131119 [TBL] [Abstract][Full Text] [Related]
20. Characterization of supraspinal antinociceptive actions of opioid delta agonists in the rat. Ossipov MH; Kovelowski CJ; Nichols ML; Hruby VJ; Porreca F Pain; 1995 Sep; 62(3):287-293. PubMed ID: 8657428 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]